期刊文献+

促凝血药的分类及临床合理应用的研究进展 被引量:1

Advances in classification and clinical rational application of coagulant promoters
原文传递
导出
摘要 促凝血药是指能促进血液凝固或降低毛细血管通透性,制止出血的药物,本文将常用的促凝血药按作用机制分类,并比较不同药物的不良反应和使用注意事项。为避免促凝血药的不合理使用而引起不良反应,临床使用时应注意根据其止血作用机制掌握其适应证,从而选择合适药物并关注其注意事项。 Coagulation-promoting drugs refer to drugs that can promote blood coagulation or reduce capillary permeability and stop bleeding.In this paper,the commonly used anticoagulant drugs were classified according to the mechanism of action,and the adverse reactions and matters needing attention of different drugs were compared.In order to avoid adverse reactions caused by irrational use of anticoagulants,clinical use should pay attention to grasp its indications according to its hemostatic mechanism,so as to select appropriate drugs and pay attention to its matters needing attention.
作者 魏凤 欧阳林旗 邓桂明 WEI Feng;OU YANG Lin-qi;DENG Gui-ming(The First Affiliated Hospital of Hunan University of Chinese Medicine,Changsha 410007,China)
出处 《临床合理用药杂志》 2019年第15期171-174,共4页 Chinese Journal of Clinical Rational Drug Use
基金 湖南省自然科学基金科卫联合项目(2018JJ6040)
关键词 促凝药 分类 合理使用 Coagulants Classification Rational clinical administration
  • 相关文献

参考文献10

二级参考文献72

共引文献81

同被引文献14

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部